Neoadjuvant sintilimab plus chemotherapy in EGFR-mutant non-small cell lung cancer (NEOTIDE/CTONG2104): phase II trial and correlative genomic analysis in China. - Zhang C; Jiang BY; Yan LX; Peng LS; Li JH; Chen ZY; Sun YX; Su J; Liao RQ; Dong S; Yan HH; Xu CR; et al. (EClinicalMedicine, 2026)